Displaying 1901 - 1920 of 2211
Watson Pharmaceuticals, Inc. and Andrx Corporation., In the Matter of
A consent order settled charges that Watson Pharmaceuticals, Inc.’s proposed $1.9 billion acquisition of Andrx Corporation, would have likely led to competitive problems in the markets for 13 generic drug products. Watson was required to end its marketing agreements with Interpham Holdings, divest Andrx’s right to develop, make, and market generic extended release tablets that correct the effects of type 2 diabetes, and divest Andrx’s rights and assets related to the developing and marketing of 11 generic oral contraceptives.
There is a related federal proceeding and two related administrative proceedings:
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610139
Docket Number
C-4172
FTC Charges Real Estate Groups with Anticompetitive Conduct in Limiting Consumers' Choice in Real Estate Services
Date
The Federal Trade Commission today charged two real estate groups operating multiple listing services in the Detroit, Michigan, area with illegally restraining competition by limiting consumers’...
FTC Finds Rambus Unlawfully Obtained Monopoly Power
Date
By a unanimous vote, the Federal Trade Commission has determined that computer technology developer Rambus, Inc. unlawfully monopolized the markets for four computer memory technologies that have been...
Oct25
Competition Policy and the Real Estate Industry: A Public Workshop hosted by the Federal Trade Commission and Department of Justice
The FTC and the Department of Justice hosted a public workshop that focused on issues related to the competitiveness of the residential real estate industry, and covered topics such as multiple...
FTC Resolves Aloha Petroleum Litigation
Date
The Federal Trade Commission today announced that, because of changed circumstances, it has asked the Federal District Court for the District of Hawaii to dismiss the FTC’s complaint seeking an...
Dual Consent Orders Resolve Competitive Concerns About Chevrons $18 Billion Purchase of Unocal, FTCs 2003 Complaint Against Unocal
Date
Two consent orders announced by the Federal Trade Commission today both resolve the competitive concerns about Chevron Corporation’s (Chevron) proposed $18 billion acquisition of Unocal Corporation...
FTC Seeks Court Order to Force Blockbuster to Comply with Premerger Rules
Date
The Federal Trade Commission today filed a motion in U.S. District Court for the District of Columbia, pursuant to Section 7A(g)(2) of the Clayton Act, 15 U.S.C. § 18a(g)(2), to require Blockbuster...
Feb18
Town Meetings on Patent System Reform
The FTC, the National Academies' Board on Science, Technology, and Economic Policy (STEP), and the American Intellectual Property Law Association (AIPLA) co-sponsored a nationwide series of Town...
Jan14
Oil Industry Merger Effects
The FTC hosted a public conference to examine two recent studies focusing on the price effects of mergers and concentration in the United States petroleum industry. The conference brought together a...
Protecting Competition, FTC Clears Genzyme Corp.'s $1 Billion Acquisition of Ilex Oncology, Inc.
Date
The Federal Trade Commission today announced that it will conditionally allow Genzyme Corporation’s (Genzyme) proposed $1 billion acquisition of ILEX Oncology, Inc. (Ilex), provided the companies...
Dec15
Peer-to-Peer File-Sharing Technology: Consumer Protection and Competition Issues
-
The workshop is the latest in a series of efforts to assess the impact of new and significant technologies on consumers and businesses. P2P file-sharing technology enables individuals to share files...
Displaying 1901 - 1920 of 2211